Palliative Care Works and 10 year anniversary of the Palliative Care Toolkit
OxCERPC hosted the AGM and annual conference on 22.09.2018. The conference theme was Global Palliative Care: Focus on the Family. We were delighted to provide the venue and support the day administratively.
‘The consortium is based in the United Kingdom and focuses upon the development of palliative care in hospice and home-based settings, in developing countries and resource-limited situations.’
The day included talks and workshops.
- David Oliviere: The family of palliative care: east meets west
- Martin Becker: Paediatric training experience in Rwanda
- Liz Bryan: Delivering QELCA programme abroad
- Helen Bennett: Children’s palliative care – insufficiently seen and heard
- Interviews with the international St Christopher’s bursary students
- Round the world in 75 minutes: Ethiopia, Bethlehem, Nepal and more
Palliative Care Toolkit for Resource Limited Health Settings
You may be interested in reading The Lancet Commission Report: Alleviating the access abyss in palliative care and pain relief – an imperative of universal health coverage.
The lack of global access to pain relief and palliative care throughout the life cycle constitutes a global crisis, and action to close this divide between rich and poor is a moral, health, and ethical imperative. The need for palliative care and pain relief has been largely ignored. Yet, palliative care and pain relief are essential elements of universal health coverage (UHC).
This Lancet Commission aims to (1) quantify the heavy burden of serious health-related suffering associated with a need for palliative care and pain relief; (2) identify and cost an essential package of palliative care and pain relief health services that would alleviate this burden; (3) measure the unmet need of an indispensable component of the package—off patent, oral, and injectable morphine; and (4) outline national and global health-system strategies to expand access to palliative care and pain relief as an integral component of UHC while minimising the risk of diversion and non-medical use.